Marek Wardęcki
6PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|May 01, 2025
Confirmation of Fixed Quarterly Riliprubart Regimen in Patients with Cold Agglutinin Disease Using Population PK/PD and Exposure-Response Analyses.Timothy Chow, Marek Wardecki, Michael Storek
|Feb 22, 2024
COVID-19 vaccine safety and immunogenicity in patients with cold agglutinin disease receiving concomitant sutimlimab.Bruno Fattizzo, Alexander Röth, Catherine M Broome
|May 29, 2023
Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease.Alexander Röth, Wilma Barcellini, Shirley D'Sa
|Jun 10, 2022
Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial.Alexander Röth, Sigbjørn Berentsen, Wilma Barcellini
|Jun 02, 2022
Sustained sutimlimab response for 3 years in patients with cold agglutinin disease: A phase I, open-label, extension trial.Georg Gelbenegger, Ulrich Jaeger, Michael Fillitz
|Nov 15, 2021
Sutimlimab, an investigational C1s inhibitor, effectively prevents exacerbation of hemolytic anemia in a patient with cold agglutinin disease undergoing major surgery.Tor Henrik A Tvedt, Egil Steien, Bente Øvrebø
Pageof 1
Frequent Collaborators
3 joint publications
Alexander Röth
2 joint publications
Bernd Jilma
2 joint publications
Wilma Barcellini
2 joint publications
Catherine M Broome
1 joint publications
Tor Henrik A Tvedt
1 joint publications
Georg Gelbenegger
1 joint publications
Michael Fillitz
1 joint publications
Shirley D'Sa
1 joint publications
Christian Schoergenhofer
1 joint publications
Marc Michel
